Does EVOLOCUMAB Cause Dry eye? 131 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 131 reports of Dry eye have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
131
Reports of Dry eye with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Dry eye From EVOLOCUMAB?
Of the 131 reports, 4 (3.1%) required hospitalization.
Is Dry eye Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 131 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Dry eye?
DUPILUMAB (10,892)
CYCLOSPORINE (1,310)
ADALIMUMAB (1,253)
METHOTREXATE (1,023)
LIFITEGRAST (1,013)
ETANERCEPT (992)
TOFACITINIB (756)
LENALIDOMIDE (649)
TOCILIZUMAB (565)
CENEGERMIN-BKBJ (537)
Which EVOLOCUMAB Alternatives Have Lower Dry eye Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE